- Home
- MCHX vs VTGN Comparison
MCHX vs VTGN Comparison
Compare MCHX & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCHX | VTGN |
|---|---|---|
| Founded | 2003 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 28.8M |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | MCHX | VTGN |
|---|---|---|
| Price | $1.63 | $0.66 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $0.90 |
| AVG Volume (30 Days) | 17.3K | ★ 5.8M |
| Earning Date | 11-13-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $46,494,000.00 | $721,000.00 |
| Revenue This Year | N/A | $54.26 |
| Revenue Next Year | $6.70 | $478.23 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.26 | $0.68 |
| 52 Week High | $2.31 | $5.14 |
Technical Indicators
Market Signals| Indicator | MCHX | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 22.46 |
| Support Level | $1.60 | $0.68 |
| Resistance Level | $1.73 | $0.75 |
| Average True Range (ATR) | 0.07 | 0.20 |
| MACD | 0.00 | -0.30 |
| Stochastic Oscillator | 20.01 | 0.03 |
Price Performance
Historical ComparisonAbout MCHX Marchex Inc. Class B
Marchex Inc harnesses the power of AI and conversational intelligence to provide actionable insights aligned with prescriptive vertical market data analytics, driving operational excellence and revenue acceleration. Marchex enables executive, sales, and marketing teams to optimize customer journey experiences across communications channels, enabling enterprise strategies, empowering businesses to increase revenue through informed decision-making and strategic execution.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.